|
ES2601896T3
(es)
|
2004-11-24 |
2017-02-16 |
Fred Hutchinson Cancer Research Center |
Procedimientos de uso de la IL-21 en la inmunoterapia adoptiva y la identificación de antígenos tumorales
|
|
EP3974520A1
(en)
|
2013-05-14 |
2022-03-30 |
Board of Regents, The University of Texas System |
Human application of engineered chimeric antigen receptor (car) t-cells
|
|
WO2014190273A1
(en)
|
2013-05-24 |
2014-11-27 |
Board Of Regents, The University Of Texas System |
Chimeric antigen receptor-targeting monoclonal antibodies
|
|
CA3190002A1
(en)
|
2014-02-14 |
2015-08-20 |
Board Of Regents, The University Of Texas System |
Chimeric antigen receptors and methods of making
|
|
GB201506423D0
(en)
|
2015-04-15 |
2015-05-27 |
Tc Biopharm Ltd |
Gamma delta T cells and uses thereof
|
|
WO2016073629A1
(en)
|
2014-11-05 |
2016-05-12 |
Board Of Regents, The University Of Texas System |
Chimeric antigen receptors (car) to selectively target protein complexes
|
|
IL252131B2
(en)
*
|
2014-11-17 |
2023-04-01 |
Adicet Bio Inc |
Transgenic gamma delta T cells
|
|
US20220280564A1
(en)
*
|
2014-11-21 |
2022-09-08 |
Immatics US, Inc. |
Methods for expanding t cells for the treatment of cancer and related malignancies
|
|
EP3804741A3
(en)
|
2015-02-24 |
2021-07-14 |
Board of Regents, The University of Texas System |
Selection methods for genetically-modified t cells
|
|
CA2977818A1
(en)
|
2015-03-11 |
2016-09-15 |
Board Of Regents, The University Of Texas System |
Transposase polypeptides and uses thereof
|
|
GB201507368D0
(en)
|
2015-04-30 |
2015-06-17 |
Ucl Business Plc |
Cell
|
|
WO2016179684A1
(en)
*
|
2015-05-11 |
2016-11-17 |
University Health Network |
Method for expansion of double negative regulatory t cells
|
|
MX386334B
(es)
*
|
2015-05-12 |
2025-03-18 |
Memorial Sloan Kettering Cancer Center |
Cèlulas t y sus usos en el tratamiento de trastornos linfoproliferativos asociados al virus de epstein-barr.
|
|
US11166983B2
(en)
*
|
2015-06-09 |
2021-11-09 |
Lymphact—Lymphocyte Activation Technologies, S.A. |
Methods for the production of TCRγδ+ T cells
|
|
DK3307875T3
(da)
*
|
2015-06-09 |
2022-03-21 |
Lymphact Lymphocyte Activation Tech S A |
Fremgangsmåder til fremstilling af tcr-gamma-delta+-t-celler
|
|
CN105112370B
(zh)
*
|
2015-08-25 |
2019-02-05 |
杭州优善生物科技有限公司 |
一种体外刺激外周血γδT细胞高效增殖的方法及其应用
|
|
EP3340997B1
(en)
*
|
2015-08-25 |
2024-02-14 |
The UAB Research Foundation |
Methods for stem cell transplantation
|
|
KR20180042449A
(ko)
|
2015-09-15 |
2018-04-25 |
보드 오브 리전츠, 더 유니버시티 오브 텍사스 시스템 |
T 세포 수용체(tcr) 결합 항체 및 이의 용도
|
|
CN105624107B
(zh)
*
|
2015-09-21 |
2020-06-12 |
杭州优善生物科技有限公司 |
一种多种淋巴细胞亚群的扩增方法及其应用
|
|
EP3368075B1
(en)
|
2015-10-27 |
2020-01-29 |
Board of Regents, The University of Texas System |
Chimeric antigen receptor molecules and uses thereof
|
|
CA3003077A1
(en)
|
2015-10-30 |
2017-05-04 |
King's College London |
Expansion of non-haematopoietic tissue-resident .gamma.delta. t cells and uses of these cells
|
|
MX2018013864A
(es)
|
2016-05-12 |
2019-06-10 |
Adicet Bio Inc |
Métodos para la expansión selectiva de poblaciones de células t gama y composicicones de estas.
|
|
WO2018081784A1
(en)
*
|
2016-10-31 |
2018-05-03 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Artificial antigen presenting cells for expanding immune cells for immunotherapy
|
|
TWI788307B
(zh)
*
|
2016-10-31 |
2023-01-01 |
美商艾歐凡斯生物治療公司 |
用於擴增腫瘤浸潤性淋巴細胞之工程化人造抗原呈現細胞
|
|
CN110494558B
(zh)
*
|
2017-02-08 |
2023-07-07 |
新加坡科技研究局 |
Gamma delta t细胞和增强其杀肿瘤活性的方法
|
|
US11629340B2
(en)
|
2017-03-03 |
2023-04-18 |
Obsidian Therapeutics, Inc. |
DHFR tunable protein regulation
|
|
GB201707048D0
(en)
*
|
2017-05-03 |
2017-06-14 |
King S College London |
Expansion of gamma delta cells, compositions, and methods of use thereof
|
|
CN109337872B
(zh)
*
|
2017-07-27 |
2023-06-23 |
上海细胞治疗研究院 |
高效扩增car-t细胞的人工抗原递呈细胞及其用途
|
|
US20200297871A1
(en)
*
|
2017-09-15 |
2020-09-24 |
King's College London |
Compositions and methods for enhancing gamma delta t cells in the gut
|
|
CN107794269A
(zh)
*
|
2017-09-30 |
2018-03-13 |
成都美杰赛尔生物科技有限公司 |
促进基因编辑t细胞活化及扩增的生物膜、制法及应用
|
|
TWI687227B
(zh)
*
|
2017-10-03 |
2020-03-11 |
生倍科技股份有限公司 |
用於t細胞免疫療法之組合及其用途
|
|
JP7227630B2
(ja)
|
2017-10-12 |
2023-02-22 |
マックマスター ユニバーシティー |
Ｙ１８２ｔ突然変異を有するｔ細胞－抗原カプラおよびその方法ならびに使用
|
|
MX2020005005A
(es)
|
2017-11-15 |
2020-08-27 |
Adicet Bio Inc |
Métodos para la expansión selectiva de poblaciones de células t gamma delta delta 3 y composiciones de estas.
|
|
CN108588023B
(zh)
*
|
2018-05-09 |
2020-02-14 |
河北森朗生物科技有限公司 |
一种生产嵌合抗原受体修饰的γδT细胞的方法
|
|
US10640562B2
(en)
|
2018-07-17 |
2020-05-05 |
Mcmaster University |
T cell-antigen coupler with various construct optimizations
|
|
BR112021005184A8
(pt)
*
|
2018-09-19 |
2022-08-16 |
Lava Therapeutics B V |
Imunoglobulina cd1d de dupla ação
|
|
KR20210069665A
(ko)
*
|
2018-09-27 |
2021-06-11 |
포스포감, 인크. |
동종이계 감마/델타-t 세포의 확장 및 사용을 위한 방법 및 조성물
|
|
MX2021003744A
(es)
*
|
2018-10-01 |
2021-06-23 |
Adicet Bio Inc |
Composiciones y métodos relacionados con linfocitos t gamma delta modificados y no modificados para el tratamiento de tumores sólidos.
|
|
JP7687952B2
(ja)
|
2018-10-01 |
2025-06-03 |
アディセット セラピューティクス， インク． |
血液腫瘍を治療するための遺伝子操作しているγδ－Ｔ細胞及び遺伝子操作していないγδ－Ｔ細胞に関する組成物及び方法
|
|
GB201818243D0
(en)
|
2018-11-08 |
2018-12-26 |
Gammadelta Therapeutics Ltd |
Methods for isolating and expanding cells
|
|
AU2020225597A1
(en)
*
|
2019-02-24 |
2021-10-07 |
Gamida-Cell Ltd. |
Method of homing and retention of gammadelta T cells for generating cell compositions for use in therapy
|
|
AU2020267504A1
(en)
*
|
2019-05-08 |
2021-12-02 |
Janssen Biotech, Inc. |
Materials and methods for modulating T cell mediated immunity
|
|
WO2021016652A1
(en)
*
|
2019-07-29 |
2021-02-04 |
The University Of Melbourne |
METHODS AND COMPOSITIONS FOR MONITORING, TREATING AND PREVENTING CMV INFECTION OR GRAFT REJECTION USING γδ T-CELLS
|
|
MX2022002747A
(es)
|
2019-09-10 |
2022-04-06 |
Obsidian Therapeutics Inc |
Proteinas de fusion de ca2-il15 para regulacion ajustable.
|
|
AU2021225817A1
(en)
*
|
2020-02-24 |
2022-10-20 |
Immatics US, Inc. |
Methods for expanding T cells for the treatment of cancer and related malignancies
|
|
CN111647070B
(zh)
*
|
2020-06-17 |
2022-06-03 |
深圳豪石生物科技有限公司 |
T细胞受体或其抗原结合片段及应用
|
|
AU2021324767A1
(en)
*
|
2020-08-12 |
2023-04-13 |
University Of Central Florida Research Foundation, Inc. |
Methods and compositions for stimulating gamma delta T cells
|
|
EP4347660A4
(en)
|
2021-06-01 |
2025-06-04 |
Triumvira Immunologics USA, Inc. |
CLAUDIN-18.2 T-CELL ANTIGEN COUPLER AND USES THEREOF
|
|
CA3235971A1
(en)
*
|
2021-10-20 |
2023-04-27 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Methods and materials for expanding tumor infiltrating gamma-delta t cells
|
|
EP4433068A4
(en)
*
|
2021-11-18 |
2025-11-12 |
Univ Minnesota |
LARGE-SCALE MULTIPLICATION OF MODIFIED HUMAN GAMMA T LYMPHOCYTES
|
|
EP4183871A1
(en)
|
2021-11-23 |
2023-05-24 |
Université d'Aix-Marseille |
Process for preparing a composition comprising a combined cell population
|
|
TW202341971A
(zh)
|
2022-02-16 |
2023-11-01 |
法商普萊歐塞拉公司 |
使用car細胞及s1p受體調節劑之治療方法
|
|
PE20242341A1
(es)
*
|
2022-04-04 |
2024-12-12 |
Gammadelta Therapeutics Ltd |
Blindaje genetico novedoso
|
|
CN114645022B
(zh)
*
|
2022-05-13 |
2022-09-02 |
首都医科大学宣武医院 |
靶向CD5的CAR-γ δ T细胞及其制备方法与应用
|
|
WO2025046256A1
(en)
|
2023-08-31 |
2025-03-06 |
Universite D'aix-Marseille |
Process for preparing a composition comprising a combined cell population
|
|
CN118064364B
(zh)
*
|
2024-04-19 |
2024-07-05 |
赛德特生物制药有限公司 |
一种γδT细胞的制备方法
|